ENGINEERING ANTIBODIES FOR THERAPY

被引：64
作者：
ADAIR, JR
机构：
[1] Celltech Research Division, Celltech Ltd, Slough, Berkshire, SL1 4EN
来源：
IMMUNOLOGICAL REVIEWS | 1992年 / 130卷
关键词：
D O I：
10.1111/j.1600-065X.1992.tb01519.x
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：5 / 40
页数：36
相关论文
共 171 条
[1]  
ADAIR JR, 1991, WO9109967
[2]  
ADAIR JR, 1992, WO9201059
[3]  
AHMAD A, 1990, Molecular Biotherapy, V2, P67
[4]   SECRETION OF IMMUNOGLOBULIN-M ASSEMBLY INTERMEDIATES IN THE PRESENCE OF REDUCING AGENTS [J].
ALBERINI, CM ;
BET, P ;
MILSTEIN, C ;
SITIA, R .
NATURE, 1990, 347 (6292) :485-487
[5]  
ALEGRE ML, 1992, J IMMUNOL, V148, P3461
[6]   VECTORS BEARING A HYBRID TRP-LAC PROMOTER USEFUL FOR REGULATED EXPRESSION OF CLONED GENES IN ESCHERICHIA-COLI [J].
AMANN, E ;
BROSIUS, J ;
PTASHNE, M .
GENE, 1983, 25 (2-3) :167-178
[7]  
ANGAL S, 1992, IN PRESS MOL IMMUNOL
[8]   THE 1ST BAGSHAWE LECTURE - TOWARDS GENERATING CYTO-TOXIC AGENTS AT CANCER SITES [J].
BAGSHAWE, KD .
BRITISH JOURNAL OF CANCER, 1989, 60 (03) :275-281
[9]  
BAKER TS, 1991, ANTIBODY IMMUNOCONJ, V4, P799
[10]  
BEBBINGTON C R, 1991, Methods (Orlando), V2, P136, DOI 10.1016/S1046-2023(05)80214-2
12345678910